GGHC
Gilder Gagnon Howe & Co’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,172,785
| Closed | -$24.1M | – | 259 |
|
|
2024
Q1 | $24.1M | Sell |
1,172,785
-46,607
| -4% | -$956K | 0.3% | 76 |
|
|
2023
Q4 | $26.2M | Sell |
1,219,392
-26,807
| -2% | -$575K | 0.36% | 68 |
|
|
2023
Q3 | $25.7M | Sell |
1,246,199
-333,746
| -21% | -$6.89M | 0.39% | 61 |
|
|
2023
Q2 | $46.6M | Sell |
1,579,945
-76,452
| -5% | -$2.26M | 0.64% | 44 |
|
|
2023
Q1 | $38.2M | Sell |
1,656,397
-110,745
| -6% | -$2.55M | 0.63% | 45 |
|
|
2022
Q4 | $49.1M | Sell |
1,767,142
-96,135
| -5% | -$2.67M | 0.92% | 35 |
|
|
2022
Q3 | $57.2M | Sell |
1,863,277
-93,543
| -5% | -$2.87M | 1% | 24 |
|
|
2022
Q2 | $57.6M | Sell |
1,956,820
-662,397
| -25% | -$19.5M | 1.03% | 24 |
|
|
2022
Q1 | $84.3M | Sell |
2,619,217
-280,897
| -10% | -$9.04M | 0.78% | 41 |
|
|
2021
Q4 | $129M | Buy |
2,900,114
+97,120
| +3% | +$4.33M | 0.74% | 42 |
|
|
2021
Q3 | $141M | Sell |
2,802,994
-32,739
| -1% | -$1.65M | 0.73% | 41 |
|
|
2021
Q2 | $222M | Sell |
2,835,733
-168,820
| -6% | -$13.2M | 1.09% | 23 |
|
|
2021
Q1 | $172M | Sell |
3,004,553
-215,290
| -7% | -$12.3M | 0.92% | 30 |
|
|
2020
Q4 | $270M | Sell |
3,219,843
-96,287
| -3% | -$8.06M | 1.34% | 17 |
|
|
2020
Q3 | $119M | Sell |
3,316,130
-69,103
| -2% | -$2.48M | 0.73% | 39 |
|
|
2020
Q2 | $81.9M | Buy |
3,385,233
+124,211
| +4% | +$3M | 0.64% | 52 |
|
|
2020
Q1 | $57.1M | Buy |
+3,261,022
| New | +$57.1M | 0.68% | 55 |
|
|
2019
Q2 | – | Sell |
-596
| Closed | -$14K | – | 290 |
|
|
2019
Q1 | $14K | Sell |
596
-191
| -24% | -$4.49K | ﹤0.01% | 275 |
|
|
2018
Q4 | $16K | Sell |
787
-12,021
| -94% | -$244K | ﹤0.01% | 265 |
|
|
2018
Q3 | $278K | Sell |
12,808
-808
| -6% | -$17.5K | ﹤0.01% | 254 |
|
|
2018
Q2 | $208K | Sell |
13,616
-67
| -0.5% | -$1.02K | ﹤0.01% | 255 |
|
|
2018
Q1 | $269K | Sell |
13,683
-1,447
| -10% | -$28.4K | ﹤0.01% | 260 |
|
|
2017
Q4 | $237K | Buy |
+15,130
| New | +$237K | ﹤0.01% | 265 |
|